Hormone Treatment, Estrogen Receptor Polymorphisms and Mortality: A Prospective Cohort Study-Reference-Cited by-同舟云学术

Hormone Treatment, Estrogen Receptor Polymorphisms and Mortality: A Prospective Cohort Study

Published:2012-03-23 Issue:3 Volume:7 Page:e34112
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ryan Joanne,Canonico Marianne,Carcaillon Laure,Carrière Isabelle,Scali Jacqueline,Dartigues Jean-Francois,Dufouil Carole,Ritchie Karen,Scarabin Pierre-Yves,Ancelin Marie-Laure

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. Prevalence of hot flushes and night sweats around the world: a systematic review.;EW Freeman;Climacteric,2007

3. Long term hormone therapy for perimenopausal and postmenopausal women.;C Farquhar;Cochrane Database Syst Rev,2009

4. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.;M Canonico;Circulation,2007

5. Estrogen replacement therapy and mortality among older women. The study of osteoporotic fractures.;JA Cauley;Arch Intern Med,1997

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic polymorphisms in CYP19A1 and ESR1 are associated with serum CK activity after prolonged running in men;Journal of Applied Physiology;2022-04-01

2. Estrogen Receptor 1 Gene rs22346939 and rs9340799 Variants are Associated with Major Depressive Disorder and its Clinical Features;Current Neurovascular Research;2021-08-11

3. Estrogen receptor alpha gene variant, PvuII (rs2234693), as a potential pharmacogenetic biomarker for aneurysmal subarachnoid hemorrhage in postmenopausal women;The Pharmacogenomics Journal;2020-02-04

4. ESR1 rs2234693 Polymorphism Is Associated with Muscle Injury and Muscle Stiffness;Medicine & Science in Sports & Exercise;2019-01

5. Amplified Crosstalk Between Estrogen Binding and GFR Signaling Mediated Pathways of ER Activation Drives Responses in Tumors Treated with Endocrine Disruptors;Recent Patents on Anti-Cancer Drug Discovery;2018-10-03